메뉴 건너뛰기




Volumn 14, Issue 8, 2013, Pages 843-849

GnRH-agonist triggering to avoid ovarian hyperstimulation syndrome: A review of the evidence

Author keywords

Agonist triggering; Art; hCG; OHSS; Prevention

Indexed keywords

ANGIOTENSIN; CHORIONIC GONADOTROPIN; DOPAMINE; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HISTAMINE; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LEUPRORELIN; LUTEINIZING HORMONE; PROGESTERONE; PROSTAGLANDIN; VASCULOTROPIN;

EID: 84881365231     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/13894501113149990163     Document Type: Article
Times cited : (7)

References (56)
  • 1
    • 0026763156 scopus 로고
    • Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment
    • Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992; 58: 249-61.
    • (1992) Fertil Steril , vol.58 , pp. 249-261
    • Navot, D.1    Bergh, P.A.2    Laufer, N.3
  • 2
    • 84881351128 scopus 로고    scopus 로고
    • Ovulation Induction: European Practice in Gynaecology and Obstetrics Series; Tarlatzis BC Ed. Amsterdam: Elsevier
    • Pellicer A, Garcia-Velasco J. Ovarian hyperstimulation syndrome. In: Ovulation Induction: European Practice in Gynaecology and Obstetrics Series; Tarlatzis BC Ed. Amsterdam: Elsevier. 2003; pp. 249-67.
    • (2003) Ovarian Hyperstimulation Syndrome , pp. 249-267
    • Pellicer, A.1    Garcia-Velasco, J.2
  • 3
    • 0034002055 scopus 로고    scopus 로고
    • Distinction between early and late ovarian hyperstimulation syndrome
    • Mathur RS, Akande AV, Keay SD, et al. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000; 73: 901-97.
    • (2000) Fertil Steril , vol.73 , pp. 901-997
    • Mathur, R.S.1    Akande, A.V.2    Keay, S.D.3
  • 4
    • 0038423919 scopus 로고    scopus 로고
    • The Ovarian Reninangiotensin System (OVRAS): A Possible Role In the Pathogenesis of the Ovarian Hyperstimulation Syndrome
    • Pellicer A, Simón C, Bonilla-Musoles F et al., Eds. Serono Symposia Publications
    • Palumbo A, Montes De Oca MJ, et al. The ovarian reninangiotensin system (OVRAS): a possible role in the pathogenesis of the ovarian hyperstimulation syndrome. In: Ovarian hyperstimulation syndrome: pathophysiology, prevention and treatment; Pellicer A, Simón C, Bonilla-Musoles F et al., Eds. Serono Symposia Publications, 1999; pp.17-29.
    • (1999) Ovarian hyperstimulation syndrome: Pathophysiology, prevention and treatment , pp. 17-29
    • Palumbo, A.1    Montes De Oca, M.J.2
  • 5
    • 0025806420 scopus 로고
    • In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17, 20-desmolase deficiency
    • Pellicer A, Miro F, Sampaio M, et al. In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17, 20-desmolase deficiency. Fertil Steril 1991; 55: 970-5.
    • (1991) Fertil Steril , vol.55 , pp. 970-975
    • Pellicer, A.1    Miro, F.2    Sampaio, M.3
  • 6
    • 9244223621 scopus 로고    scopus 로고
    • Expression of endothelin-1 gene and protein in human granulosa cells
    • Magini A, Granchi S, Orlando C, et al. Expression of endothelin-1 gene and protein in human granulosa cells. J Clin Endocrinol Metab 1996; 81: 1428-33.
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 1428-1433
    • Magini, A.1    Granchi, S.2    Orlando, C.3
  • 7
    • 0028814949 scopus 로고
    • Increased capillary induced by human follicular fluid: A hypothesis for an ovarian origin of the hyperstimulation syndrome
    • Goldsman MP, Pedram A, Dominguez CE, et al. Increased capillary induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fert Steril 1995; 63: 268-72.
    • (1995) Fert Steril , vol.63 , pp. 268-272
    • Goldsman, M.P.1    Pedram, A.2    Dominguez, C.E.3
  • 8
    • 0036259602 scopus 로고    scopus 로고
    • The role of endothelium in the patogénesis of ovarian hyperstimulation síndrome
    • Albert C, Garrido N, Mercader A, et al. The role of endothelium in the patogénesis of ovarian hyperstimulation síndrome. Mol Hum Reprod 2002; 8: 409-18.
    • (2002) Mol Hum Reprod , vol.8 , pp. 409-418
    • Albert, C.1    Garrido, N.2    Mercader, A.3
  • 9
    • 34250723951 scopus 로고    scopus 로고
    • Review of evidence base strategies to prevente ovarian hyperstimulation syndrome
    • Mathur R, Kailasam C, Jenkins J. Review of evidence base strategies to prevente ovarian hyperstimulation syndrome. Hum Fertil (Camb) 2007; 10: 75-85.
    • (2007) Hum Fertil (Camb) , vol.10 , pp. 75-85
    • Mathur, R.1    Kailasam, C.2    Jenkins, J.3
  • 10
    • 0037837014 scopus 로고    scopus 로고
    • Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF recpetor-2 expression that is associated to vascular hyperpermeability
    • Gómez R, Simón C, Remohí J, et al. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF recpetor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 2003; 68: 2164-71.
    • (2003) Biol Reprod , vol.68 , pp. 2164-2171
    • Gómez, R.1    Simón, C.2    Remohí, J.3
  • 11
    • 0036827816 scopus 로고    scopus 로고
    • Vascular endotelial growth factor receptor-2 activation induces vascular permeability in hyperstimulation rats, and this effect is prevented by receptor blockade
    • Gómez R, Simón C, Remohí J, et al. Vascular endotelial growth factor receptor-2 activation induces vascular permeability in hyperstimulation rats, and this effect is prevented by receptor blockade. Endocrinology 2002; 143: 4339-48.
    • (2002) Endocrinology , vol.143 , pp. 4339-4348
    • Gómez, R.1    Simón, C.2    Remohí, J.3
  • 12
    • 79958719365 scopus 로고    scopus 로고
    • Differential regulation of vascular mediators by hCG versus GnRH agonists
    • Cerrillo M, Pacheco A, Rodriguez S, et al. Differential regulation of vascular mediators by hCG versus GnRH agonists. Hum Reprod 2010; 25(supl 1): i249.
    • (2010) Hum Reprod , vol.25 , Issue.SUPPL. 1
    • Cerrillo, M.1    Pacheco, A.2    Rodriguez, S.3
  • 13
    • 0017816022 scopus 로고
    • Ovarian hyperstimulation syndrome: A current survey
    • Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978; 30: 255-68.
    • (1978) Fertil Steril , vol.30 , pp. 255-268
    • Schenker, J.G.1    Weinstein, D.2
  • 14
    • 0024334512 scopus 로고
    • Ovarian hyperstimulation syndrome: An update review
    • Golan A, Ron-el R, Herman A, et al. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989; 44: 430-40.
    • (1989) Obstet Gynecol Surv , vol.44 , pp. 430-440
    • Golan, A.1    Ron-El, R.2    Herman, A.3
  • 15
    • 0038689325 scopus 로고    scopus 로고
    • Ovarian hyperstimulation syndrome: Classifications and critical analysis of preventive measures
    • Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 2003; 9: 275-89.
    • (2003) Hum Reprod Update , vol.9 , pp. 275-289
    • Aboulghar, M.A.1    Mansour, R.T.2
  • 16
    • 85026152880 scopus 로고    scopus 로고
    • Bilateral pleural effusion and ascites in the ovarian hyperstimulation syndrome
    • Calvo-Romero JM, Lima-Rodríguez EM. Bilateral pleural effusion and ascites in the ovarian hyperstimulation syndrome. Eur J Emerg Med 2004; 11: 348-50.
    • (2004) Eur J Emerg Med , vol.11 , pp. 348-350
    • Calvo-Romero, J.M.1    Lima-Rodríguez, E.M.2
  • 17
    • 0031659728 scopus 로고    scopus 로고
    • Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome
    • Fábregues F, Balasch J, Manau D, et al. Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. Hum Reprod 1998; 13: 2406-10.
    • (1998) Hum Reprod , vol.13 , pp. 2406-2410
    • Fábregues, F.1    Balasch, J.2    Manau, D.3
  • 19
    • 33750210002 scopus 로고    scopus 로고
    • Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis
    • Kolibianakis EM, Collins J, Tarlatzis BC, et al. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006; 12: 657-71.
    • (2006) Hum Reprod Update , vol.12 , pp. 657-671
    • Kolibianakis, E.M.1    Collins, J.2    Tarlatzis, B.C.3
  • 20
    • 0025146431 scopus 로고
    • Use of gonadotropinreleasing hormone agonist to trigger follicular maturation for in vitro fertilization
    • Gonen Y, Balakier H, Powell W, et al. Use of gonadotropinreleasing hormone agonist to trigger follicular maturation for in vitro fertilization. Clin Endocrinol Metab 1990; 71: 918-22.
    • (1990) Clin Endocrinol Metab , vol.71 , pp. 918-922
    • Gonen, Y.1    Balakier, H.2    Powell, W.3
  • 21
    • 0025883825 scopus 로고
    • Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist
    • Itskovitz J, Boldes R, Levron J, et al. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril 1991; 56: 213-20.
    • (1991) Fertil Steril , vol.56 , pp. 213-220
    • Itskovitz, J.1    Boldes, R.2    Levron, J.3
  • 23
    • 0026766599 scopus 로고
    • Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in vitro fertilization
    • Segal S, Casper RF. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in vitro fertilization. Fertil Steril 1992; 57: 1254-8.
    • (1992) Fertil Steril , vol.57 , pp. 1254-1258
    • Segal, S.1    Casper, R.F.2
  • 24
    • 0141606263 scopus 로고    scopus 로고
    • No supplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in vitro fertilization patients after ovarian stimulation with recombinant follicle stimulating hormone and GnRH antagonist cotreatment
    • Beckers NG, Macklon NS, Eijkemans MJ, et al. No supplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in vitro fertilization patients after ovarian stimulation with recombinant follicle stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 2003; 88: 4186-92.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 4186-4192
    • Beckers, N.G.1    Macklon, N.S.2    Eijkemans, M.J.3
  • 25
    • 18044400218 scopus 로고    scopus 로고
    • Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin
    • Parneix I, Emperaire JC, Ruffie A, et al. Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin Gynecol Obstet Fertil. 2001; 29: 100-5.
    • (2001) Gynecol Obstet Fertil , vol.29 , pp. 100-105
    • Parneix, I.1    Emperaire, J.C.2    Ruffie, A.3
  • 26
    • 59349114171 scopus 로고    scopus 로고
    • Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: Findings of a large retrospective cohort study
    • Bodri D, Guillén J, Galindo A, et al. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril 2009; 91: 365-71.
    • (2009) Fertil Steril , vol.91 , pp. 365-371
    • Bodri, D.1    Guillén, J.2    Galindo, A.3
  • 27
    • 63249084659 scopus 로고    scopus 로고
    • No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles
    • Hernandez ER, Gomez-Palomares JL, Ricciarelli E. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles. Fertil Steril 2009; 91: 1358-61.
    • (2009) Fertil Steril , vol.91 , pp. 1358-1361
    • Hernandez, E.R.1    Gomez-Palomares, J.L.2    Ricciarelli, E.3
  • 28
    • 63249114848 scopus 로고    scopus 로고
    • Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: A rationale for OHSS reduction
    • Cerrillo M, Rodríguez S, Mayoral M, et al. Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction. Fertil Steril 2009; 91: 1526-8.
    • (2009) Fertil Steril , vol.91 , pp. 1526-1528
    • Cerrillo, M.1    Rodríguez, S.2    Mayoral, M.3
  • 29
    • 27144499019 scopus 로고    scopus 로고
    • A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists
    • Kolibianakis EM, Schultze-Mosgau A, Schroer A, et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 2005; 20: 2887-92.
    • (2005) Hum Reprod , vol.20 , pp. 2887-2892
    • Kolibianakis, E.M.1    Schultze-Mosgau, A.2    Schroer, A.3
  • 30
    • 20444394425 scopus 로고    scopus 로고
    • GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: A prospective randomized study
    • Humaidan P, Bredkjaer HE, Bungum L, et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2005; 20: 1213-20.
    • (2005) Hum Reprod , vol.20 , pp. 1213-1220
    • Humaidan, P.1    Bredkjaer, H.E.2    Bungum, L.3
  • 31
    • 33751073732 scopus 로고    scopus 로고
    • GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS
    • Engmann L, Siano L, Schmidt D, et al. GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS. Reprod Biomed Online 2006; 13: 639-44.
    • (2006) Reprod Biomed Online , vol.13 , pp. 639-644
    • Engmann, L.1    Siano, L.2    Schmidt, D.3
  • 32
    • 77649211847 scopus 로고    scopus 로고
    • Cycles triggered with GnRH agonist: Exploring low-dose HCG for luteal support
    • Castillo JC, Dolz M, Bienvenido E, et al. Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support. Reprod Biomed Online 2010; 20: 175-81.
    • (2010) Reprod Biomed Online , vol.20 , pp. 175-181
    • Castillo, J.C.1    Dolz, M.2    Bienvenido, E.3
  • 33
    • 33751230189 scopus 로고    scopus 로고
    • Triggering ovulation with gonadotropin-releasing hormone agonist does not compromise embryo implantation rates
    • Acevedo B, Gómez-Palomares JL, Ricciarelli MD, et al. Triggering ovulation with gonadotropin-releasing hormone agonist does not compromise embryo implantation rates. Fertil Steril 2006; 86: 1682-7.
    • (2006) Fertil Steril , vol.86 , pp. 1682-1687
    • Acevedo, B.1    Gómez-Palomares, J.L.2    Ricciarelli, M.D.3
  • 34
    • 34347209929 scopus 로고    scopus 로고
    • Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles
    • Saphiro B, Daneshmand S, Garner F, et al. Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles Fertil Steril 2006; 88: 237-9.
    • (2006) Fertil Steril , vol.88 , pp. 237-239
    • Saphiro, B.1    Daneshmand, S.2    Garner, F.3
  • 35
    • 84894403337 scopus 로고    scopus 로고
    • A full year OHSS-free: The ultimaté protocol for egg donors
    • Álvarez A, Matey S, Ruiz M, et al. A full year OHSS-free: the ultimaté protocol for egg donors. Hum Reprod 2009; 24 (suppl 21): i20.
    • (2009) Hum Reprod , vol.24 , Issue.SUPPL. 21
    • Álvarez, A.1    Matey, S.2    Ruiz, M.3
  • 36
    • 70449397316 scopus 로고    scopus 로고
    • GnRH agonist versus recombinant HCG in an oocyte donation programme: A randomised, prospective, controlled, assessor-blind study
    • Melo M, Busso CE, Bellver J, et al. GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomised, prospective, controlled, assessor-blind study. Reprod Biomed Online 2009; 19: 486-92.
    • (2009) Reprod Biomed Online , vol.19 , pp. 486-492
    • Melo, M.1    Busso, C.E.2    Bellver, J.3
  • 37
    • 63249084659 scopus 로고    scopus 로고
    • No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles
    • Hernandez ER, Gomez-Palomares JL, Ricciarelli E. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles. Fertil Steril 2009; 91: 1358-61.
    • (2009) Fertil Steril , vol.91 , pp. 1358-1361
    • Hernandez, E.R.1    Gomez-Palomares, J.L.2    Ricciarelli, E.3
  • 38
    • 77957807220 scopus 로고    scopus 로고
    • GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation
    • Oktay K, Türkçüolu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online 2010; 20: 783-8.
    • (2010) Reprod Biomed Online , vol.20 , pp. 783-788
    • Oktay, K.1    Türkçüolu, I.2    Rodriguez-Wallberg, K.A.3
  • 39
    • 84859161529 scopus 로고    scopus 로고
    • Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment
    • Domingo J, Guillén V, Ayllón Y, et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril 2012; 97: 930-4.
    • (2012) Fertil Steril , vol.97 , pp. 930-934
    • Domingo, J.1    Guillén, V.2    Ayllón, Y.3
  • 40
    • 32644447350 scopus 로고    scopus 로고
    • GnRH Agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: A systematic review and meta-analysis
    • Griesinger G, Diedrich K, Devroey P, et al. GnRH Agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 2006; 12: 159-68.
    • (2006) Hum Reprod Update , vol.12 , pp. 159-168
    • Griesinger, G.1    Diedrich, K.2    Devroey, P.3
  • 41
    • 33747059580 scopus 로고    scopus 로고
    • Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: A pilot study
    • Humaidan P, Bungum L, Bungum M, et al. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006; 13: 173-8.
    • (2006) Reprod Biomed Online , vol.13 , pp. 173-178
    • Humaidan, P.1    Bungum, L.2    Bungum, M.3
  • 42
    • 75749138165 scopus 로고    scopus 로고
    • 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: A prospective, randomised, controlled study
    • Humaidan P, Ejdrup Bredkjaer H, et al. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomised, controlled study. Fertil Steril 2010; 93: 847-54.
    • (2010) Fertil Steril , vol.93 , pp. 847-854
    • Humaidan, P.1    Ejdrup Bredkjaer, H.2
  • 43
    • 79951945981 scopus 로고    scopus 로고
    • A novel method of luteal supplementation with recombinant LH, when a GnRHAgonist is used instead of HCG for ovulation triggering. A randomized prospective proof of concept study
    • Papanikolaou EG, Verpoest W, Fatemi H, et al. A novel method of luteal supplementation with recombinant LH, when a GnRHAgonist is used instead of HCG for ovulation triggering. A randomized prospective proof of concept study. Fertil Steril 2011; 3: 1174-7
    • (2011) Fertil Steril , vol.3 , pp. 1174-1177
    • Papanikolaou, E.G.1    Verpoest, W.2    Fatemi, H.3
  • 44
    • 33645847254 scopus 로고    scopus 로고
    • Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: A prospective randomized trial
    • Babayof R, Margalioth EJ, Huleihel M, et al. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod 2006; 21: 1260-5
    • (2006) Hum Reprod , vol.21 , pp. 1260-1265
    • Babayof, R.1    Margalioth, E.J.2    Huleihel, M.3
  • 45
    • 80052902532 scopus 로고    scopus 로고
    • An OHSS-Free Clinic by segmentation of IVF treatment
    • Devroey P, Polyzos N, Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod 2011; 26: 2593-7.
    • (2011) Hum Reprod , vol.26 , pp. 2593-2597
    • Devroey, P.1    Polyzos, N.2    Blockeel, C.3
  • 46
    • 24644455926 scopus 로고    scopus 로고
    • Highly efficient vitrification method for cryopreservation of human oocytes
    • Kuwayama M, Vajta G, Kato O, et al. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005; 11: 300-8.
    • (2005) Reprod Biomed Online , vol.11 , pp. 300-308
    • Kuwayama, M.1    Vajta, G.2    Kato, O.3
  • 47
    • 44349124425 scopus 로고    scopus 로고
    • Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by Cryotop method
    • Cobo A, Kuwayama M, Pérez S, et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by Cryotop method. Fertil Steril 2007; 89: 1657-64.
    • (2007) Fertil Steril , vol.89 , pp. 1657-1664
    • Cobo, A.1    Kuwayama, M.2    Pérez, S.3
  • 48
    • 77955962803 scopus 로고    scopus 로고
    • Use of cryo-banked oocytes in an ovum donation programme: A prospective, randomized, controlled, clinical trial
    • Cobo A, Meseguer M, Remohí J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod 2010; 25: 2239-46.
    • (2010) Hum Reprod , vol.25 , pp. 2239-2246
    • Cobo, A.1    Meseguer, M.2    Remohí, J.3    Pellicer, A.4
  • 49
    • 72849148916 scopus 로고    scopus 로고
    • Embryo development of fresh "versus" vitrified metaphase IIoocytes after ICSI: A prospective randomizaed sibling-oocyte study
    • Rienzi L, Romano S, Albricci L, et al. Embryo development of fresh "versus" vitrified metaphase IIoocytes after ICSI: a prospective randomizaed sibling-oocyte study. Hum Reprod 2010; 25: 66-73.
    • (2010) Hum Reprod , vol.25 , pp. 66-73
    • Rienzi, L.1    Romano, S.2    Albricci, L.3
  • 50
    • 79951947677 scopus 로고    scopus 로고
    • Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: A new strategy to avoid ovarian hyperstimulation syndrome
    • Herrero L, Pareja S, Losada C, Cobo A, Pellicer A, García-Velasco JA. Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome. Fertil Steril 2011; 93: 1137-40.
    • (2011) Fertil Steril , vol.93 , pp. 1137-1140
    • Herrero, L.1    Pareja, S.2    Losada, C.3    Cobo, A.4    Pellicer, A.5    García-Velasco, J.A.6
  • 51
    • 84857789379 scopus 로고    scopus 로고
    • Agonist trigger: What is the best approach? Agonist trigger with vitrification of oocytes or embryos
    • García-Velasco JA. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos. Fertil Steril 2012; 97: 527-8.
    • (2012) Fertil Steril , vol.97 , pp. 527-528
    • García-Velasco, J.A.1
  • 52
    • 54149102502 scopus 로고    scopus 로고
    • A randomised controlled study of human Day 3 embryo cryopreservation by slow freezing or vitrification: Vitrification is associated with higher survival, metabolism and blastocyst formation
    • Balaban B, Urman B, Ata B, et al. A randomised controlled study of human Day 3 embryo cryopreservation by slow freezing or vitrification: vitrification is associated with higher survival, metabolism and blastocyst formation. Hum Reprod 2008; 23: 1976-82.
    • (2008) Hum Reprod , vol.23 , pp. 1976-1982
    • Balaban, B.1    Urman, B.2    Ata, B.3
  • 53
    • 79960647582 scopus 로고    scopus 로고
    • Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: A prospective randomized trial comparing fresh and frozen-thawed embryo transfer in high responders
    • Shapiro B, Daneshmand S, Garner F, Aguirre M, Hudson C, Thomas S. evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in high responders. Fertil Steril 2011; 96: 516-8.
    • (2011) Fertil Steril , vol.96 , pp. 516-518
    • Shapiro, B.1    Daneshmand, S.2    Garner, F.3    Aguirre, M.4    Hudson, C.5    Thomas, S.6
  • 54
    • 84894404366 scopus 로고    scopus 로고
    • Endometrial Receptivity Arrays (ERA) with different luteal support protocols after triggering final oocyte maturation with GnRH agonist
    • Bermejo A, Cerrillo M, Ortega I, et al. Endometrial Receptivity Arrays (ERA) with different luteal support protocols after triggering final oocyte maturation with GnRH agonist. Hum Reprod 2012; 27(suppl 2): ii93-ii95.
    • (2012) Hum Reprod , vol.27 , Issue.SUPPL. 2
    • Bermejo, A.1    Cerrillo, M.2    Ortega, I.3
  • 55
    • 78650418973 scopus 로고    scopus 로고
    • A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature
    • Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril 2011; 95: 50-60.
    • (2011) Fertil Steril , vol.95 , pp. 50-60
    • Díaz-Gimeno, P.1    Horcajadas, J.A.2    Martínez-Conejero, J.A.3
  • 56
    • 84867835285 scopus 로고    scopus 로고
    • Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in rFSH stimulated and GnRH antagonist co-treated IVF cycles
    • Humaidan P, Van Vaerenbergh I, Bourgain C, et al. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in rFSH stimulated and GnRH antagonist co-treated IVF cycles Hum Reprod 2012; 27: 3259-72.
    • (2012) Hum Reprod , vol.27 , pp. 3259-3272
    • Humaidan, P.1    van Vaerenbergh, I.2    Bourgain, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.